| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.15B | 2.37B | 2.17B | 1.20B | 2.05B |
| Gross Profit | 2.38B | 1.71B | 1.64B | 741.00M | 1.68B |
| EBITDA | 2.19B | 1.59B | 1.54B | 655.00M | 1.60B |
| Net Income | 1.30B | 1.52B | 1.52B | 600.00M | 1.57B |
Balance Sheet | |||||
| Total Assets | 31.23B | 28.25B | 23.80B | 22.40B | 20.84B |
| Cash, Cash Equivalents and Short-Term Investments | 924.00M | 635.00M | 535.00M | 303.00M | 372.00M |
| Total Debt | 15.99B | 13.76B | 11.95B | 12.38B | 11.16B |
| Total Liabilities | 16.92B | 14.90B | 12.60B | 12.84B | 11.97B |
| Stockholders Equity | 14.32B | 13.36B | 11.20B | 9.55B | 8.87B |
Cash Flow | |||||
| Free Cash Flow | 1.14B | 1.28B | 1.00B | 746.00M | 935.00M |
| Operating Cash Flow | 1.14B | 1.28B | 1.00B | 746.00M | 935.00M |
| Investing Cash Flow | -2.86B | -3.41B | -489.00M | -2.10B | -3.39B |
| Financing Cash Flow | 1.78B | 2.42B | -284.00M | 1.21B | 2.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $5.12B | 10.94 | 16.94% | 7.17% | 11.60% | 9.38% | |
64 Neutral | $3.21B | 13.71 | 8.30% | 11.70% | 24.12% | 1.09% | |
63 Neutral | $13.28B | 10.89 | 9.22% | 9.64% | 10.34% | -24.16% | |
62 Neutral | $2.69B | 10.01 | 15.88% | 10.00% | -15.32% | -12.29% | |
59 Neutral | $16.22B | 31.80 | 16.10% | 3.03% | 25.02% | 235.70% | |
56 Neutral | $2.96B | -9.10 | 0.18% | 18.52% | -13.67% | -48.49% |
On February 25, 2026, Ares Capital Corporation and its wholly owned subsidiary Ares Capital JB Funding LLC amended their long-standing SMBC Funding Facility with Sumitomo Mitsui Banking Corporation, increasing total commitments from $1.1 billion to $1.6 billion and slightly lowering the interest spread over SOFR and the base rate. The amendment also expanded the facility’s accordion feature, allowing potential upsizing from a prior cap of $1.3 billion to as much as $2.5 billion under certain conditions, enhancing Ares Capital’s available funding capacity while leaving other key terms largely unchanged and maintaining compliance with existing covenant and leverage restrictions under the Investment Company Act of 1940.
The changes to the SMBC Funding Facility strengthen Ares Capital’s balance sheet flexibility and liquidity resources to support its lending activities in the middle-market segment. By securing a larger, lower-cost credit facility and the ability to further scale it, the company reinforces its competitive positioning in private credit markets and provides additional headroom to grow its portfolio, which may benefit both borrowers seeking financing solutions and investors focused on Ares Capital’s capacity to deploy capital efficiently.
The most recent analyst rating on (ARCC) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Ares Capital stock, see the ARCC Stock Forecast page.
On February 4, 2026, Ares Capital Corporation reported its financial results for the fourth quarter and full year ended December 31, 2025, alongside declaring a first-quarter 2026 dividend of $0.48 per share, payable on March 31, 2026 to shareholders of record on March 13, 2026. For 2025, the company generated GAAP net income of $1.86 per share and core EPS of $2.01, supported by $1.415 billion in net investment income, while maintaining an annual dividend of $1.92 per share, matching the prior year; the year also saw portfolio investments at fair value rise to $29.5 billion and total assets increase to $31.2 billion, indicating balance-sheet expansion despite periods of net realized losses and fluctuating unrealized gains and losses. These results underscore Ares Capital’s continued ability to cover and sustain its dividend from earnings, reinforcing its appeal to income-focused investors and highlighting its scale and resilience within the business development company market.
The most recent analyst rating on (ARCC) stock is a Buy with a $24.50 price target. To see the full list of analyst forecasts on Ares Capital stock, see the ARCC Stock Forecast page.
On January 12, 2026, Ares Capital Corporation completed the issuance and sale of $750 million aggregate principal amount of 5.250% unsecured notes due April 12, 2031, under a supplemental indenture with U.S. Bank Trust Company, National Association as trustee. The notes, which pay interest semiannually starting April 12, 2026, include covenants tied to Investment Company Act leverage requirements, reporting obligations if Ares Capital ceases to be an Exchange Act filer, and a change-of-control repurchase feature if the notes are downgraded below investment grade by all three major rating agencies. Ares Capital intends to use the net proceeds to repay borrowings under its credit facilities, with capacity to reborrow for general corporate purposes including new portfolio investments, thereby optimizing its liability structure and preserving funding flexibility. In a related step, on January 5, 2026, the company entered into a purchase agreement with a syndicate of underwriters for the notes and simultaneously executed a $750 million interest rate swap with SMBC Capital Markets, Inc., converting its fixed 5.250% coupon into a floating rate based on one‑month SOFR plus 1.7217% through April 12, 2031, which aligns its funding costs more closely with short-term rates and may reduce interest rate risk.
The most recent analyst rating on (ARCC) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on Ares Capital stock, see the ARCC Stock Forecast page.
On December 3, 2025, Ares Capital Corporation completed a $1.0 billion term debt securitization through its subsidiary, Ares Direct Lending CLO 7 LLC. This transaction, known as the ADL CLO 7 Debt Securitization, involves issuing various classes of notes backed by a diversified portfolio of first lien senior secured loans. The company plans to use the proceeds to repay outstanding debt and invest in portfolio companies, enhancing its financial flexibility and strategic positioning in the market.
The most recent analyst rating on (ARCC) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Ares Capital stock, see the ARCC Stock Forecast page.